TrianglePUBLICATIONS · 29738613
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2018 Aug 1
- First author
- Keller FG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Keller FG
- type
- Author
- name
- Castellino SM
- type
- Author
- name
- Chen L
- type
- Author
- name
- Pei Q
- type
- Author
- name
- Voss SD
- type
- Author
- name
- McCarten KM
- type
- Author
- name
- Senn SL
- type
- Author
- name
- Buxton AB
- type
- Author
- name
- Bush R
- type
- Author
- name
- Constine LS
- type
- Author
- name
- Schwartz CL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Keller FG
- type
- Author
- name
- Castellino SM
- type
- Author
- name
- Chen L
- type
- Author
- name
- Pei Q
- type
- Author
- name
- Voss SD
- type
- Author
- name
- McCarten KM
- type
- Author
- name
- Senn SL
- type
- Author
- name
- Buxton AB
- type
- Author
- name
- Bush R
- type
- Author
- name
- Constine LS
- type
- Author
- name
- Schwartz CL
- type
- Author
- bibliography ids
- nci-bib-1e881e897ee94561d6401a50
- book metadata
- content sha256
- 9da38dd126f34b5a6809c448e524403324add4aac499f87f7c4d3dec1c1d1141
- document type
- citation
- dois
- 10.1002/cncr.31519
- electronic publication date
- display
- 2018 May 8
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29738613
- immutable id
- pubmed:29738613@9da38dd126f34b5a6809c448e524403324add4aac499f87f7c4d3dec1c1d1141
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 15
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 3210-3219
- volume
- 124
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29738613
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- 894e24a6e89c3e891ac860fccd86c818dda44ecef1110698b2ba088e1d6b3b93
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Aug 1
- precision
- day
- year
- 2018
- publication types
- Clinical Trial
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
Preserved source evidence · Not medical advice